Mar 28, 2022Alpha Tau Medical Announces Full Year 2021 Financial Results and Provides Corporate Update-Debuted as publicly-traded oncology company in March 2022 under symbol DRTS while raising approximately $90 million in gross proceeds-...
Mar 22, 2022Alpha Tau Medical Ltd. Appoints Ruth Alon to its Board of DirectorsJERUSALEM, March 21, 2022 -- Alpha Tau Medical Ltd. (Nasdaq: DRTS), the developer of the innovative alpha-radiation cancer therapy Alpha...
Mar 8, 2022Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business CombinationAlpha Tau Is Expected to Commence Trading on Nasdaq Under the Ticker "DRTS" on March 8, 2022 JERUSALEM and WILMINGTON, Del., March 7,...